Albus : Award Recipients

award_recipients_title

Award Recipients

award-recipients-2025

Award Recipient 2025

Inés Moreno González

Department of Cell Biology of the University of Malaga
Malaga, Spain.

Project: Uncovering Albumin’s Therapeutic Potential to Modulate Tau Pathology by Blood Exchange

award-recipients-2024

Award Recipient 2024

Bryce A. Kerlin, MD

The Abigail Wexner Research Institute at Nationwide Children’s Hospital
Ohio, USA.

Project: Albumin-Dependent Endothelial Cytoprotection

award-recipients-2023

Award Recipients 2023

Robert Hahn, MD, PhD

Karolinska Institute, Danderyds Hospital
Stockholm, Sweden

Project: 5% and 20% albumin vs Ringer for goal-directed fluid therapy in major surgery

Alessandra Di Masi, PhD

Department of Science, Section of Biomedical Sciences and Technologies
Roma Tre University
Rome, Italy

Project: Dissecting the role of human serum albumin in the innate immunity response

award-recipients-2022

Award Recipients 2022

Margret Paar, PhD

Division of Medicinal Chemistry, Otto-Loewi Research Center
Medical University of Graz
Graz, Austria

Project: What makes Albumin (in)effective?

Mattia Busana, MD

Department of Anesthesiology and Intensive Care
University Medical Center Göttingen
Göttingen, Germany

Project: Lung edema and VILI development: does the fluid type matter?

Publication: Albumin kinetics, intravascular fluid volume, and respiratory function in pigs ventilated at different levels of mechanical power following crystalloid vs. albumin infusion.

award-recipients-2021

Award Recipients 2021

Christoph R. Behem, MD

Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine
University Medical Center Hamburg-Eppendorf
Hamburg, Germany

Project: The use of Albumin for optimization of spinal cord microcirculatory blood‐flow and oxygenation in an experimental model of spinal cord ischemia.

Martin Sebastian Winkler, MD

Department of Anesthesiology and Intensive Care
University Medicine Goettingen
Goettingen, Germany

Project: Non-oncotic effects of albumin as a carrier of sphingosine-1-phosphate for the restoration of endothelial cell barriers and immune cell function in sepsis.

Publication: The potential effect of albumin replacement on immune modulation and sphingosine 1-phosphate dynamics.

award-recipients-2020

Award Recipients 2020

Mar Hernández, PhD

Vall d'Hebron Research Institute
Hospital Vall d'Hebron
Barcelona, Spain

Project: Nanotechnology albumin-based approach for the diagnosis and treatment of Alzheimer's Disease

Hafid Ait-Oufella, MD, PhD

Division of Intensive Care Medicine
St-Antoine Hospital
Paris, France

Project: Impact of albumin infusion on tissue perfusion in septic shock patients. A prospective pathophysiological study

Publication: Albumin versus saline infusion for sepsis related peripheral tissue hypoperfusion: a proof of concept prospective study

award-recipients-2019

Award Recipients 2019

Prof. Davide Chiumello

Direttore SC Anestesia e Rianimazione
Ospedale San Paolo – Polo Universitario, ASST Santi Paolo e Carlo
Milan, Italy

Project: Effect of volume EXpansion witH ALbumin vs. crystalloid on EIT-derived expiratory lung impedance in critically ill, hemodynamically unstable patients. A single-blind, randomized and controlled study (the EXHALE study)

Aurora Pujol, MD, PhD

Neurometabolic Diseases Laboratory
Bellvitge Biomedical Research Institute IDIBELL- Hospital Duran i Reynals
Barcelona, Spain

Project: Human albumin in plasma exchange as a novel approach for adrenoleukodystrophy

award-recipients-2018

Award Recipients 2018

Paolo Caraceni, MD

Department of Medical and Surgical Sciences
Alma Mater Studiorum University of Bologna
Bologna, Italy

Project: Long‐term albumin administration in patients with decompensated cirrhosis: clinical and pathophysiological implications

Publication: On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites - PubMed (nih.gov)

Hanadi Sleiman, PhD

Department of Chemistry

McGill University
Montreal, Canada

Project: Albumin as a passive targeting agent: effect of the protein binding on stability, bio distribution and therapeutic outcome of oligonucleotides and DNA nanoparticles

Publication: Detailed cellular assessment of albumin-bound oligonucleotides: Increased stability and lower non-specific cell uptake - PubMed (nih.gov)

award-recipients-2017

Award Recipients 2017

Anna ROIG, PhD

Institut de Ciència de Materials de Barcelona
Consejo Superior de Investigaciones Científicas
Bellaterra (Barcelona), Spain

Project: Albumin-iron oxide nanocages

Publication: Insights into Preformed Human Serum Albumin Corona on Iron Oxide Nanoparticles: Structure, Effect of Particle Size, Impact on MRI Efficiency, and Metabolization | ACS Applied Bio Materials

Karl OETTL, PhD

Institute of Physiological Chemistry

Medical University of Graz
Graz, Austria

Project: Effect of albumin redox state on the intracellular redox balance in cell culture

Publication: Albumin in patients with liver disease shows an altered conformation - PubMed (nih.gov)

award-recipients-2016

Award Recipients 2016

Joan CLÀRIA, Bsc, PhD

Hospital Clínic
Faculty of Medicine, University of Barcelona
Barcelona, Spain

Project: Effects of native (reduced) and oxidized albumin forms on human leukocyte function

Publication: Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis - PubMed (nih.gov)

Rudolf E. STAUBER, MD

Division of Gastroenterology and Hepatology

Department of Internal Medicine, Medical University of Graz
Graz, Austria

Project: Effect of albumin infusion on oxidative albumin modification and albumin binding capacity
Publication: Effect of albumin infusion on oxidative albumin modification and albumin binding capacity in chronic liver failure

award-recipients-2015

Award Recipients 2015

Pietro CAIRONI, MD

Department of Pathophysiology and Transplantation
Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, University of Milan
Milan, Italy

Project: Albumin administration as a therapeutic approach to attenuate sepsis-induced glycocalyx disruption in human septic shock

Publication: Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS - PubMed (nih.gov)